ArticleTrials2020

A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial.

Shaoying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.